Apheresis market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a latest ...

The growth of the market is driven by a rising incidence of trauma and injury cases, upsurging number of complex surgical ...

AFERsmart is an integrated unit to perform blood purification treatments like Plasma Exchange, Double Filtration, Selective Double Filtration, Double Filtration with Adsorption and Hemoperfusion ...

Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.

The hazard ratio for benefit from drug treatment was 0.34 (p = 0.02) and remained virtually the same after the 23 patients who were on apheresis were excluded from the analysis, albeit at a lower ...

MONROE — About 45 people came to an American Red Cross blood drive Thursday at Monroe Church of the Nazarene that honored ...

The latest science on how blood levels of HDL, LDL and more relate to cardiovascular health ...

Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Bioline RX Ltd Sponsored ADR (BLRX – Research Report), retaining ...

The transfusion medicine rotation allows residents to be active members of the healthcare team that oversees the release of blood products, therapeutic apheresis procedures, and apheresis collections ...

An IA column that selectively removes Lp(a) has also been developed. [13] A radically different approach to Lp apheresis involves extracorporeal precipitation of LDL by the addition of heparin to ...